EP1272624A4 - A process for the production of human interferon alpha from genetically engineered yeast - Google Patents
A process for the production of human interferon alpha from genetically engineered yeastInfo
- Publication number
- EP1272624A4 EP1272624A4 EP00909584A EP00909584A EP1272624A4 EP 1272624 A4 EP1272624 A4 EP 1272624A4 EP 00909584 A EP00909584 A EP 00909584A EP 00909584 A EP00909584 A EP 00909584A EP 1272624 A4 EP1272624 A4 EP 1272624A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- production
- genetically engineered
- interferon alpha
- human interferon
- engineered yeast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2000/000339 WO2001068827A1 (en) | 2000-03-16 | 2000-03-16 | A process for the production of human interferon alpha from genetically engineered yeast |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1272624A1 EP1272624A1 (en) | 2003-01-08 |
EP1272624A4 true EP1272624A4 (en) | 2004-06-16 |
Family
ID=11003897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00909584A Withdrawn EP1272624A4 (en) | 2000-03-16 | 2000-03-16 | A process for the production of human interferon alpha from genetically engineered yeast |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1272624A4 (en) |
JP (1) | JP2003526365A (en) |
CN (1) | CN1452658A (en) |
AU (1) | AU2000231863A1 (en) |
CA (1) | CA2402562A1 (en) |
WO (1) | WO2001068827A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004039996A1 (en) * | 2002-11-01 | 2004-05-13 | Cadila Healthcare Limited | Mthod for producing recombinant human interferon alpha 2b polypeptide in pichia pastoris |
AU2008201682B2 (en) * | 2004-02-02 | 2011-02-24 | Ambrx, Inc. | Modified human interferon polypeptides and their uses |
GB2429207A (en) | 2004-02-02 | 2007-02-21 | Ambrx Inc | Modified human interferon polypeptides and their uses |
CU24158B1 (en) * | 2012-09-18 | 2016-03-30 | Ct De Ingeniería Genética Y Biotecnología | 1-KESTOSA OBTAINING METHOD |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0606917A2 (en) * | 1993-01-13 | 1994-07-20 | The Green Cross Corporation | A methylotropic and glucotropic mutant strain for producing a heterologous protein |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL90021A0 (en) * | 1988-04-25 | 1989-12-15 | Phillips Petroleum Co | Process for the production of interferon |
-
2000
- 2000-03-16 CA CA002402562A patent/CA2402562A1/en not_active Abandoned
- 2000-03-16 JP JP2001567311A patent/JP2003526365A/en active Pending
- 2000-03-16 EP EP00909584A patent/EP1272624A4/en not_active Withdrawn
- 2000-03-16 WO PCT/IB2000/000339 patent/WO2001068827A1/en active Application Filing
- 2000-03-16 CN CN00819549.8A patent/CN1452658A/en active Pending
- 2000-03-16 AU AU2000231863A patent/AU2000231863A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0606917A2 (en) * | 1993-01-13 | 1994-07-20 | The Green Cross Corporation | A methylotropic and glucotropic mutant strain for producing a heterologous protein |
Non-Patent Citations (3)
Title |
---|
CREGG J M ET AL: "RECENT ADVANCES IN THE EXPRESSION OF FOREIGN GENES IN PICHIA PASTORIS", BIO/TECHNOLOGY, NATURE PUBLISHING CO. NEW YORK, US, vol. 11, no. 8, August 1993 (1993-08-01), pages 905 - 910, XP001093882, ISSN: 0733-222X * |
ROSENFELD: "Use of P. pastoris for expression of recombinant proteins", METHODS IN ENZYMOLOGY, vol. 306, 1999, pages 154 - 169, XP009029632 * |
See also references of WO0168827A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2402562A1 (en) | 2001-09-20 |
AU2000231863A1 (en) | 2001-09-24 |
WO2001068827A1 (en) | 2001-09-20 |
JP2003526365A (en) | 2003-09-09 |
EP1272624A1 (en) | 2003-01-08 |
CN1452658A (en) | 2003-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0402027A3 (en) | Process for the preparation of a xantophyll | |
HK1075414A1 (en) | Sustained release preparations and process for producing the same | |
EP1466596A4 (en) | Novel microsphere and method for production thereof | |
EP1405912A4 (en) | Genetically modified ecarin and process for producing the same | |
HU9901526D0 (en) | Pharmaceutical intermediates and process for producing them | |
EP1391518A4 (en) | Process for producing peptide | |
HUP0200567A3 (en) | Process for the fermentative production of o-acetyl-serin | |
EP1406855A4 (en) | Novel process for preparing rac-bicalutamide and its intermediates | |
EP1272624A4 (en) | A process for the production of human interferon alpha from genetically engineered yeast | |
AU2003291476A8 (en) | Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide | |
GC0000363A (en) | Process for the production of vinyl acetate | |
AU2003247023A8 (en) | A process for the preparation of dispersible tablet of cephalexin | |
IL152996A0 (en) | Novel interferon for the treatment of multiple sclerosis | |
GB2397819B (en) | (R)-Hydroxycarboxylic acid producing recombinant microorganism and process for preparing (R)-hydroxycarboxylic acid using the same | |
HUP0002751A3 (en) | Novel grignard-reagents and process for producing thereof | |
IL144809A0 (en) | Method for the production of aliphatic fluoroformates | |
MXPA03002221A (en) | Coupled production of two esters. | |
AU3185400A (en) | A process for producing purified biologically active, free form of recombinant human interferon gamma | |
HUP0301635A3 (en) | Continuous process for the production of optically pure (s)-betha-hydroxy-gamma-butyrolactone | |
AU7964000A (en) | Process for producing ball-shape food | |
HUP0104761A3 (en) | Modification of interferon alpha production | |
IL147529A0 (en) | A method for the production of soybean sugars and the product produced thereof | |
HK1052926A1 (en) | Process for the production of trifluoromethylacetophenones | |
PL372298A1 (en) | Method for producing interferon | |
GB9920906D0 (en) | Increased production of interferon-a |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20021010 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040503 |
|
17Q | First examination report despatched |
Effective date: 20050401 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: SHANTHA BIOTECHNICS LIMITED |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20081001 |